Browsing Category
Healthcare Industry News
2470 posts
Inside Smart Meter’s iAmbientHealth: the sensor that watches without wearables or cameras
Smart Meter launches iAmbientHealth, a radar-based contactless monitoring sensor predicting patient health risks days in advance.
Inside the Crucial Catch partnership: how the American Cancer Society and NFL are tackling cancer disparities with new grants
Discover how the American Cancer Society and NFL’s Crucial Catch program is boosting cancer screening access and saving lives nationwide.
Kovo+ Holdings CEO Justin Anderson resigns suddenly — Can Michael Steele steady the company?
Kovo+ Holdings (TSXV: KOVO) CEO Justin Anderson resigns for health reasons; Michael Steele steps in. Discover what this leadership change means for investors.
ImExHS stock edges higher as new Colombia oncology deal marks A$1.4m ARR breakthrough
ImExHS (ASX: IME) secures A$1.4M Colombia oncology contract with Oncolife. Can SaaS imaging and AI radiology services restore investor confidence?
ClorDiSys doubles chlorine dioxide sterilization capacity as demand for safer ethylene oxide alternatives surges
ClorDiSys doubles chlorine dioxide sterilization capacity with new chambers and R&D expansion, strengthening its role as a safer alternative to ethylene oxide.
Why Jeju-grown matcha and hojicha are gaining global attention as premium tea rivals to Japan
Clean Jeju Green Tea Cooperative Sumang expands global reach with matcha and Hojicha. Discover how Jeju-grown teas are reshaping the premium wellness market.
Is neuromodulation entering its next growth cycle? Lessons from Medtronic, Axonics, and Boston Scientific
Neuromodulation is moving into its next growth cycle. Explore how Medtronic, Boston Scientific, and Axonics are reshaping bladder control and chronic care.
Profound Medical stock surges as Texas program expands access to TULSA prostate treatment under Medicare
Profound Medical stock surged after Texas expanded access to its TULSA procedure under Medicare. Explore the financials, risks, and investor outlook.
From stigma to scale: How bladder control therapies are evolving from hidden struggle to healthcare priority
Bladder control therapies are moving from stigma to mainstream care. Discover how rising awareness and innovation are reshaping treatment options globally.
How Celltrion’s $330m Eli Lilly deal positions it for a new era of U.S. biomanufacturing
Celltrion’s $330M purchase of Eli Lilly’s U.S. plant signals a tariff-proof pivot in biosimilars, reshaping pharma manufacturing in the U.S. today.